<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01193556</url>
  </required_header>
  <id_info>
    <org_study_id>PEAK VP-00075</org_study_id>
    <nct_id>NCT01193556</nct_id>
  </id_info>
  <brief_title>PEAK PlasmaBlade TnA Versus Traditional Electrosurgery in Subcapsular Tonsillectomy</brief_title>
  <acronym>PRECISE</acronym>
  <official_title>A Prospective, Randomized, Double-blinded, Controlled Study to Evaluate Use of the PEAK PlasmaBlade TnA in Subcapsular Tonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Surgical Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Surgical Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical study is to evaluate the operative performance of the PEAK
      PlasmaBladeÂ® TnA during subcapsular tonsillectomy; to monitor and record post-operative
      clinical outcome variables; and to compare these endpoints to the Standard of Care (SOC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tonsillectomy is performed in response to cases of repeated occurrence of acute tonsillitis
      or adenoiditis, obstructive sleep apnea, nasal airway obstruction, snoring, or peritonsillar
      abscess.

      The PEAK PlasmaBlade uses pulsed radiofrequency (RF) energy and a highly-insulated handpiece
      design to enable precision cutting and coagulation at the point of application. The
      PlasmaBlade has received FDA clearance for use in plastic, general, orthopedic, and ear,
      nose, and throat (ENT) surgery, and has demonstrated a significantly reduced thermal injury
      profile in incised tissue compared to traditional electrosurgical devices. It is hypothesized
      that this benefit may improve the post-operative outcome of patients undergoing
      tonsillectomy.

      Two study sites were granted approval for this prospective randomized study. Potential
      subjects were screened against the inclusion and exclusion criteria of the study protocol and
      were required to provide informed consent for themselves (adults) or for their child prior to
      enrollment. Following enrollment, subjects were prospectively randomized to the SOC or
      PlasmaBlade (PB or PEAK) study groups and scheduled for tonsillectomy or tonsillectomy and
      adenoidectomy (TnA).
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Termination due to acquisition of PEAK Surgical by Medtronic
  </why_stopped>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Pain</measure>
    <time_frame>10 days immediately following surgery</time_frame>
    <description>The primary outcome measure will be pain in each treatment group, as measured by visual analog scale twice daily in the 10 day period directly following surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative Time, Estimated Blood Loss (EBL), Diet Volume and Activity Level</measure>
    <time_frame>1-2 weeks post-operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Tonsillitis</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PlasmaBlade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEAK PlasmaBlade TnA</intervention_name>
    <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
    <arm_group_label>PlasmaBlade</arm_group_label>
    <other_name>PEAK</other_name>
    <other_name>PlasmaBlade</other_name>
    <other_name>Plasma Blade</other_name>
    <other_name>TnA</other_name>
    <other_name>Tonsil and Adenoid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Traditional Electrosurgery with scalpel</intervention_name>
    <description>Traditional electrosurgery for the tonsillectomy.</description>
    <arm_group_label>Standard of Care</arm_group_label>
    <other_name>Electrosurgery</other_name>
    <other_name>Electrocautery</other_name>
    <other_name>Bovie</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children &amp; adolescents: Age 3-17; Adults: 18 and older

          2. Physically healthy, stable weight

          3. Requiring tonsillectomy and adenoidectomy per widely accepted indications

          4. For adults, subject must understand the nature of the procedure and provide written
             informed consent.

          5. For children and adolescents age 7 to 17, subject must understand the nature of the
             procedure and be able to give verbal assent prior to the procedure. In addition,
             parent or guardian must provide written informed consent.

          6. For children under 7 years old, parent or guardian must understand the nature of the
             procedure and provide written informed consent.

          7. Subject (or responsible parent or guardian) must be willing and able to comply with
             all follow-up evaluations, including completion of study data sheets.

        Exclusion Criteria:

          1. Children: Age 2 and under

          2. Bleeding disorder

          3. Peritonsillar abscess

          4. Requiring concomitant uvulopalatopharyngoplasty (UPPP)

          5. Anticoagulation therapy which cannot be discontinued

          6. Unable to follow instructions or complete follow-up

          7. Currently taking any medication known to affect healing

          8. Currently enrolled in another investigational device or drug trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Weeks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senta Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Spitzer, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mark Spitzer, DO</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Surgery Center Merced</name>
      <address>
        <city>Merced</city>
        <state>California</state>
        <zip>95340</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alvarado Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2010</study_first_submitted>
  <study_first_submitted_qc>September 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 2, 2010</study_first_posted>
  <results_first_submitted>November 29, 2012</results_first_submitted>
  <results_first_submitted_qc>November 29, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 3, 2013</results_first_posted>
  <last_update_submitted>November 29, 2012</last_update_submitted>
  <last_update_submitted_qc>November 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tonsillectomy</keyword>
  <keyword>PlasmaBlade</keyword>
  <keyword>Electrosurgery</keyword>
  <keyword>PEAK Surgical</keyword>
  <keyword>Medtronic Advanced Energy</keyword>
  <keyword>Medtronic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard of Care (SOC)</title>
          <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
        </group>
        <group group_id="P2">
          <title>PlasmaBlade</title>
          <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study termination</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard of Care (SOC)</title>
          <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
        </group>
        <group group_id="B2">
          <title>PlasmaBlade</title>
          <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Children (3-17 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adults (18 years and older)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>partipants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</measurement>
                    <measurement group_id="B2" value="NA">An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</measurement>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</measurement>
                    <measurement group_id="B2" value="NA">An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</measurement>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-operative Pain</title>
        <description>The primary outcome measure will be pain in each treatment group, as measured by visual analog scale twice daily in the 10 day period directly following surgery.</description>
        <time_frame>10 days immediately following surgery</time_frame>
        <population>An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care (SOC)</title>
            <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
          </group>
          <group group_id="O2">
            <title>PlasmaBlade</title>
            <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Pain</title>
          <description>The primary outcome measure will be pain in each treatment group, as measured by visual analog scale twice daily in the 10 day period directly following surgery.</description>
          <population>An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Time, Estimated Blood Loss (EBL), Diet Volume and Activity Level</title>
        <time_frame>1-2 weeks post-operatively</time_frame>
        <population>An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard of Care (SOC)</title>
            <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
          </group>
          <group group_id="O2">
            <title>PlasmaBlade</title>
            <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
          </group>
        </group_list>
        <measure>
          <title>Operative Time, Estimated Blood Loss (EBL), Diet Volume and Activity Level</title>
          <population>An integrity audit found that the data for this study could not be analyzed owing to unverifiable source documentation.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard of Care (SOC)</title>
          <description>Traditional electrosurgery will be used for the tonsillectomy.</description>
        </group>
        <group group_id="E2">
          <title>PlasmaBlade</title>
          <description>The PEAK PlasmaBlade will be used for the tonsillectomy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Postoperative bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea/vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Postoperative bleeding</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Upon Medtronic's acquisition of PEAK surgical, a study integrity audit was undertaken. Results of the audit showed that patient's rights and safety were maintained, but the source data, including baseline demographics, were unverifiable.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Robert Swain, PhD</name_or_title>
      <organization>Medtronic Surgical Technologies</organization>
      <phone>(+1-603) 294-5428</phone>
      <email>robert.e.swain@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

